Parents researching treating borderline GH deficiency in kids are often facing one of the most frustrating situations in pediatric growth medicine.
Their child is clearly not growing as expected. Growth charts may show declining percentiles. Friends and classmates seem to be growing faster. The child may be noticeably shorter than siblings or peers.
Yet when testing is performed, the results are not always clear.
The child may not meet strict criteria for classic growth hormone deficiency, but they may not appear completely normal either.
This gray zone is often referred to as borderline growth hormone deficiency.
For families, the challenge is understanding whether the child is simply a late bloomer, whether growth will eventually normalize on its own, or whether mild growth hormone dysfunction is contributing to slower growth.
The good news is that modern pediatric growth evaluation goes far beyond a single lab result. By analyzing growth velocity, bone age, hormone signals, puberty timing, family height patterns, and predicted adult height, specialists can often develop a much clearer understanding of a child's growth potential and whether intervention may be appropriate.
What Is Borderline Growth Hormone Deficiency?
Growth hormone is produced by the pituitary gland and plays a critical role in childhood growth.
It helps regulate:
- Height growth
- Bone development
- Muscle development
- Metabolism
- Body composition
- Tissue repair
In children with severe or classic growth hormone deficiency, hormone production is clearly inadequate. These children often demonstrate significantly impaired growth and abnormal testing results.
Borderline growth hormone deficiency is different.
These children may:
- Produce some growth hormone
- Have hormone levels that are technically within range
- Show mildly abnormal stimulation testing
- Have borderline IGF-1 levels
- Grow slower than expected despite "normal" evaluations
Because they do not fit neatly into a diagnostic category, families often receive mixed messages regarding treatment.
Why Borderline Cases Are So Challenging
Growth is not determined by one laboratory value.
A child can technically pass a growth hormone stimulation test and still have growth patterns that raise concern.
Likewise, a child may have borderline laboratory abnormalities while maintaining an acceptable growth rate.
This is why pediatric growth specialists focus heavily on clinical patterns.
A child may fall into the borderline category when:
- Growth hormone production appears low-normal
- Growth velocity is below expectations
- Height percentile continues to decline
- Bone age is delayed
- Predicted adult height is concerning
- No other obvious explanation is found
These children often occupy the space between normal growth and classic hormone deficiency.
Signs That May Suggest Borderline GH Deficiency
Parents often recognize concerns long before a formal diagnosis is considered.
Common signs include:
Falling Growth Percentiles
One of the earliest warning signs is movement downward on the growth chart.
Children who were previously average height may gradually become shorter relative to peers.
Parents frequently seek evaluation after noticing growth chart percentile dropping in a child over several years.
Slow Growth Velocity
Growth velocity refers to how many inches a child grows each year.
A child does not need to completely stop growing to have a problem.
Many borderline cases involve children who are still growing but at a slower rate than expected.
This is why poor growth velocity is one of the most important findings in pediatric growth evaluation.
Delayed Bone Age
Many children with borderline hormone function demonstrate delayed bone age.
This may indicate that skeletal development is progressing more slowly than chronological age.
Low-Normal IGF-1
Growth hormone stimulates production of IGF-1.
Children with low IGF-1 levels may warrant further evaluation even when other findings are inconclusive.
Short Predicted Adult Height
Parents may become concerned when projected adult height falls significantly below family expectations.
This often triggers a more detailed workup.
Borderline GH Deficiency vs Constitutional Growth Delay
One reason borderline cases are difficult is that they may resemble constitutional growth delay.
Children with constitutional delay are often called late bloomers.
These children frequently:
- Have delayed bone age
- Enter puberty later
- Remain shorter during childhood
- Continue growing later than peers
Many eventually achieve a normal adult height.
The challenge is distinguishing between a child who will naturally catch up and a child whose growth is limited by inadequate hormone signaling.
This distinction often requires years of growth data, bone age analysis, and careful monitoring.
Borderline GH Deficiency vs Idiopathic Short Stature
Another condition commonly confused with borderline GH deficiency is idiopathic short stature.
Children with idiopathic short stature are significantly shorter than average without an identifiable medical cause.
Some may have:
- Normal GH testing
- Normal labs
- Normal nutrition
- Normal health status
Yet they remain substantially shorter than expected.
Borderline GH deficiency sits between these categories because mild hormonal impairment may still contribute to growth limitations.
Why Growth Velocity Matters More Than a Single Test
Many parents assume the diagnosis depends entirely on laboratory testing.
In reality, growth patterns often tell the most important story.
A child who grows normally year after year is less concerning than a child whose growth rate steadily slows.
Children who are growing less than 2 inches per year during mid-childhood often require additional evaluation regardless of whether laboratory values appear reassuring.
This is why specialists pay close attention to:
- Annual height gain
- Growth curve trends
- Percentile movement
- Bone age progression
- Puberty timing
How Doctors Evaluate Borderline GH Deficiency
A comprehensive evaluation typically includes multiple components.
Growth Chart Analysis
The first step is understanding the child's long-term growth pattern.
Parents often benefit from reviewing height percentile chart explained for parents before their consultation.
Family Height Assessment
Genetics strongly influence final height.
Understanding parent heights helps establish realistic growth expectations.
Bone Age Imaging
A bone age test for child height provides valuable information about skeletal maturity and remaining growth potential.
IGF-1 and IGFBP-3 Testing
These markers help assess growth hormone signaling.
While not diagnostic alone, they contribute important information.
Growth Hormone Stimulation Testing
When appropriate, specialists may recommend a child growth hormone testing process involving stimulation testing.
Parents frequently review growth hormone deficiency testing protocol in children before proceeding.
Predicted Adult Height Analysis
This helps determine whether growth concerns may meaningfully affect final adult stature.
When Treatment May Be Considered
Not every child with borderline findings requires treatment.
Some children simply need monitoring.
Others may benefit from intervention when several concerning factors are present simultaneously.
Examples include:
- Persistent poor growth velocity
- Declining height percentiles
- Delayed bone age
- Low-normal IGF-1
- Predicted short adult height
- Borderline stimulation testing
Treatment decisions are individualized and based on the overall clinical picture.
Growth Hormone Therapy for Borderline Cases
In selected cases, physicians may discuss growth hormone deficiency treatment in kids even when findings are not completely definitive.
Growth hormone therapy works by:
- Increasing growth signaling
- Supporting bone growth
- Improving height velocity
- Helping children approach genetic height potential
Many families ask whether treatment can help before puberty significantly advances.
This is why understanding growth hormone therapy before growth plates close is important.
The earlier significant growth limitations are identified, the greater the opportunity to influence height outcomes.
Can Borderline Cases Respond Well to Treatment?
Many children with borderline hormone function respond favorably when treatment is carefully selected.
Response depends on factors such as:
- Age
- Diagnosis
- Bone age
- Puberty status
- Genetics
- Treatment timing
- Adherence
Parents often ask about success rate of HGH therapy in children and average height gain with growth hormone in kids, but outcomes vary substantially between patients.
The goal is not achieving a specific height target.
The goal is helping children reach closer to their natural growth potential.
Why Timing Is Critical
Growth potential decreases as growth plates mature.
This is why waiting indefinitely can reduce available options.
Children experiencing:
- Falling percentiles
- Delayed bone age
- Low growth velocity
- Borderline hormone findings
may benefit from earlier assessment rather than assuming they will eventually catch up.
Parents often review growth hormone therapy before puberty effectiveness because treatment opportunities are often greatest while substantial growth remains.
The Emotional Impact of Borderline Growth Problems
Borderline growth issues can be emotionally difficult because uncertainty often persists for years.
Children may experience:
- Lower confidence
- Social frustration
- Sports limitations
- Concerns about being smaller than peers
Parents often struggle because no single test provides a simple answer.
A comprehensive evaluation can provide clarity, realistic expectations, and a plan moving forward.
Questions Parents Should Ask During Evaluation
If your child falls into the gray zone, consider asking:
- Is growth velocity normal?
- Is bone age delayed?
- What is predicted adult height?
- Are IGF-1 levels appropriate?
- Should additional testing be considered?
- Could this be constitutional growth delay?
- Could this be idiopathic short stature?
- Is treatment likely to change the outcome?
- How much growth remains?
- How frequently should monitoring occur?
Frequently Asked Questions
What is borderline growth hormone deficiency?
Borderline GH deficiency refers to children whose growth hormone production is not clearly deficient but may still be inadequate for optimal growth.
Can a child pass GH testing and still have growth problems?
Yes. Growth patterns, growth velocity, bone age, and predicted adult height often provide important information beyond laboratory testing.
Does every borderline case require treatment?
No. Some children simply require observation and monitoring.
Is delayed bone age a good sign?
Sometimes. Delayed bone age may indicate additional growth potential remains.
Can growth hormone therapy help borderline cases?
In selected children, treatment may improve growth velocity and height outcomes when clinically appropriate.
When should parents seek evaluation?
Evaluation should be considered when a child has declining growth percentiles, poor growth velocity, delayed puberty, delayed bone age, or a predicted adult height significantly below expectations.
The Bottom Line
Treating borderline GH deficiency in kids requires looking beyond a single laboratory result.
Children in this gray zone often have growth patterns that raise concern despite not meeting strict criteria for classic growth hormone deficiency. Careful evaluation of growth velocity, bone age, IGF-1 levels, puberty timing, and predicted adult height helps determine whether monitoring alone is appropriate or whether treatment may offer meaningful benefit.
For families facing uncertainty, a comprehensive pediatric growth evaluation can provide answers, clarify risks, and help ensure that important growth opportunities are not missed while growth plates remain open.
Medically Reviewed By
Dr. Devin Stone, ND
Dr. Devin Stone is a Doctor of Naturopathic Medicine and founder of HGHforChildren.com. His clinical focus includes pediatric growth optimization, growth hormone deficiency, delayed bone age assessment, constitutional growth delay, IGF-1 evaluation, and evidence-informed therapies designed to help children maximize healthy growth potential.
References
- Pediatric Endocrine Society
- Growth Hormone Research Society
- Endocrine Society
- American Academy of Pediatrics
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Hormone Research in Paediatrics
- Journal of Clinical Endocrinology & Metabolism
Dr. Devin Stone
Contact Me
